Cargando…

A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer

PURPOSE: With the increasing interest in treatment decision-making based on risk prediction models, it is essential for clinicians to understand the steps in developing and interpreting such models. METHODS: A retrospective registry of 20 Dutch hospitals with data on patients treated for castration-...

Descripción completa

Detalles Bibliográficos
Autores principales: Veen, Kevin M., de Angst, Isabel B., Mokhles, Mostafa M., Westgeest, Hans M., Kuppen, Malou, Groot, Carin A. Uyl-de, Gerritsen, Winald R., Kil, Paul J. M., Takkenberg, Johanna J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324416/
https://www.ncbi.nlm.nih.gov/pubmed/32556680
http://dx.doi.org/10.1007/s00432-020-03286-8
_version_ 1783551937855094784
author Veen, Kevin M.
de Angst, Isabel B.
Mokhles, Mostafa M.
Westgeest, Hans M.
Kuppen, Malou
Groot, Carin A. Uyl-de
Gerritsen, Winald R.
Kil, Paul J. M.
Takkenberg, Johanna J. M.
author_facet Veen, Kevin M.
de Angst, Isabel B.
Mokhles, Mostafa M.
Westgeest, Hans M.
Kuppen, Malou
Groot, Carin A. Uyl-de
Gerritsen, Winald R.
Kil, Paul J. M.
Takkenberg, Johanna J. M.
author_sort Veen, Kevin M.
collection PubMed
description PURPOSE: With the increasing interest in treatment decision-making based on risk prediction models, it is essential for clinicians to understand the steps in developing and interpreting such models. METHODS: A retrospective registry of 20 Dutch hospitals with data on patients treated for castration-resistant prostate cancer was used to guide clinicians through the steps of developing a prediction model. The model of choice was the Cox proportional hazard model. RESULTS: Using the exemplary dataset several essential steps in prediction modelling are discussed including: coding of predictors, missing values, interaction, model specification and performance. An advanced method for appropriate selection of main effects, e.g. Least Absolute Shrinkage and Selection Operator (LASSO) regression, is described. Furthermore, the assumptions of Cox proportional hazard model are discussed, and how to handle violations of the proportional hazard assumption using time-varying coefficients. CONCLUSION: This study provides a comprehensive detailed guide to bridge the gap between the statistician and clinician, based on a large dataset of real-world patients treated for castration-resistant prostate cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-020-03286-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7324416
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73244162020-07-07 A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer Veen, Kevin M. de Angst, Isabel B. Mokhles, Mostafa M. Westgeest, Hans M. Kuppen, Malou Groot, Carin A. Uyl-de Gerritsen, Winald R. Kil, Paul J. M. Takkenberg, Johanna J. M. J Cancer Res Clin Oncol Review – Clinical Oncology PURPOSE: With the increasing interest in treatment decision-making based on risk prediction models, it is essential for clinicians to understand the steps in developing and interpreting such models. METHODS: A retrospective registry of 20 Dutch hospitals with data on patients treated for castration-resistant prostate cancer was used to guide clinicians through the steps of developing a prediction model. The model of choice was the Cox proportional hazard model. RESULTS: Using the exemplary dataset several essential steps in prediction modelling are discussed including: coding of predictors, missing values, interaction, model specification and performance. An advanced method for appropriate selection of main effects, e.g. Least Absolute Shrinkage and Selection Operator (LASSO) regression, is described. Furthermore, the assumptions of Cox proportional hazard model are discussed, and how to handle violations of the proportional hazard assumption using time-varying coefficients. CONCLUSION: This study provides a comprehensive detailed guide to bridge the gap between the statistician and clinician, based on a large dataset of real-world patients treated for castration-resistant prostate cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-020-03286-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-06-17 2020 /pmc/articles/PMC7324416/ /pubmed/32556680 http://dx.doi.org/10.1007/s00432-020-03286-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review – Clinical Oncology
Veen, Kevin M.
de Angst, Isabel B.
Mokhles, Mostafa M.
Westgeest, Hans M.
Kuppen, Malou
Groot, Carin A. Uyl-de
Gerritsen, Winald R.
Kil, Paul J. M.
Takkenberg, Johanna J. M.
A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
title A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
title_full A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
title_fullStr A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
title_full_unstemmed A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
title_short A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
title_sort clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
topic Review – Clinical Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324416/
https://www.ncbi.nlm.nih.gov/pubmed/32556680
http://dx.doi.org/10.1007/s00432-020-03286-8
work_keys_str_mv AT veenkevinm acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT deangstisabelb acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT mokhlesmostafam acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT westgeesthansm acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT kuppenmalou acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT grootcarinauylde acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT gerritsenwinaldr acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT kilpauljm acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT takkenbergjohannajm acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT veenkevinm cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT deangstisabelb cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT mokhlesmostafam cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT westgeesthansm cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT kuppenmalou cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT grootcarinauylde cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT gerritsenwinaldr cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT kilpauljm cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer
AT takkenbergjohannajm cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer